Theraclion SA (ALTHE.PA)
EUR 0.36
(-2.72%)
EUR 0.36
(-2.72%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.15 Million EUR | 49.96% |
| 2022 | -6.3 Million EUR | -33.15% |
| 2021 | -4.73 Million EUR | -10.52% |
| 2020 | -4.28 Million EUR | 5.2% |
| 2019 | -4.52 Million EUR | 35.21% |
| 2018 | -6.97 Million EUR | 1.7% |
| 2017 | -7.09 Million EUR | 5.2% |
| 2016 | -7.48 Million EUR | -3.4% |
| 2015 | -7.24 Million EUR | -46.01% |
| 2014 | -4.95 Million EUR | -9.07% |
| 2013 | -4.54 Million EUR | -24.7% |
| 2012 | -3.64 Million EUR | -74.99% |
| 2011 | -2.08 Million EUR | 8.85% |
| 2010 | -2.28 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -3.12 Million EUR | 0.0% |
| 2023 Q2 | -3.18 Million EUR | 0.0% |
| 2023 Q4 | 24.52 Thousand EUR | 0.0% |
| 2023 FY | -3.15 Million EUR | 49.96% |
| 2022 Q2 | -3.45 Million EUR | 0.0% |
| 2022 FY | -6.3 Million EUR | -33.15% |
| 2022 Q4 | -2.86 Million EUR | 0.0% |
| 2021 FY | -4.73 Million EUR | -10.52% |
| 2021 Q2 | -1.95 Million EUR | 0.0% |
| 2021 Q4 | -2.79 Million EUR | 0.0% |
| 2020 Q2 | -2.1 Million EUR | 0.0% |
| 2020 Q4 | -2.17 Million EUR | 0.0% |
| 2020 FY | -4.28 Million EUR | 5.2% |
| 2019 Q2 | -2.55 Million EUR | 0.0% |
| 2019 Q4 | -1.96 Million EUR | 0.0% |
| 2019 FY | -4.52 Million EUR | 35.21% |
| 2018 Q4 | -2.8 Million EUR | 0.0% |
| 2018 Q2 | -4.17 Million EUR | 0.0% |
| 2018 FY | -6.97 Million EUR | 1.7% |
| 2017 Q2 | -3.94 Million EUR | 0.0% |
| 2017 Q4 | -3.15 Million EUR | 0.0% |
| 2017 FY | -7.09 Million EUR | 5.2% |
| 2016 Q4 | -3.66 Million EUR | 0.0% |
| 2016 FY | -7.48 Million EUR | -3.4% |
| 2016 Q2 | -3.82 Million EUR | 0.0% |
| 2015 Q2 | -3.43 Million EUR | 0.0% |
| 2015 Q4 | -3.8 Million EUR | 0.0% |
| 2015 FY | -7.24 Million EUR | -46.01% |
| 2014 FY | -4.95 Million EUR | -9.07% |
| 2014 Q4 | -2.55 Million EUR | 0.0% |
| 2014 Q2 | -2.39 Million EUR | 0.0% |
| 2013 Q3 | -1.12 Million EUR | 50.54% |
| 2013 Q4 | -2.27 Million EUR | -103.02% |
| 2013 FY | -4.54 Million EUR | -24.7% |
| 2013 Q2 | -2.26 Million EUR | 0.0% |
| 2012 FY | -3.64 Million EUR | -74.99% |
| 2012 Q4 | -1.12 Million EUR | -22.13% |
| 2012 Q1 | -918.73 Thousand EUR | 0.0% |
| 2012 Q2 | -918.73 Thousand EUR | 0.0% |
| 2012 Q3 | -918.73 Thousand EUR | 0.0% |
| 2011 Q3 | -520.21 Thousand EUR | 0.0% |
| 2011 FY | -2.08 Million EUR | 8.85% |
| 2011 Q1 | -520.21 Thousand EUR | 0.0% |
| 2011 Q2 | -520.21 Thousand EUR | 0.0% |
| 2011 Q4 | -918.73 Thousand EUR | -76.61% |
| 2010 Q3 | -578.03 Thousand EUR | 0.0% |
| 2010 Q2 | -578.03 Thousand EUR | 0.0% |
| 2010 Q1 | -578.03 Thousand EUR | 0.0% |
| 2010 FY | -2.28 Million EUR | 0.0% |
| 2010 Q4 | -520.21 Thousand EUR | 10.0% |
| 2009 Q4 | -578.03 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Affluent Medical SA | -13.06 Million EUR | 75.861% |
| Bluelinea Société Anonyme | -1.61 Million EUR | -95.577% |
| Carmat SA | -52.51 Million EUR | 93.995% |
| Diagnostic Medical Systems S.A. | -2.26 Million EUR | -39.249% |
| Euromedis Groupe | -5.55 Million EUR | 43.245% |
| Eurobio Scientific Société anonyme | 10.14 Million EUR | 131.101% |
| Ikonisys S.A. | -2.19 Million EUR | -43.773% |
| Implanet S.A. | -6.15 Million EUR | 48.79% |
| Median Technologies SA | -23 Million EUR | 86.291% |
| SpineGuard SA | -3.97 Million EUR | 20.676% |
| Euroapi S.A. | -234.3 Million EUR | 98.654% |
| Guerbet SA | 38.67 Million EUR | 108.156% |
| Ion Beam Applications SA | 5.09 Million EUR | 161.94% |
| Koninklijke Philips N.V. | -115 Million EUR | 97.257% |
| Sequana Medical NV | -29.49 Million EUR | 89.305% |